摘要
目的分析生化检验指标在肝硬化疾病诊断价值分析。方法选择2018年11月-2019年11月该院收治的肝硬化患者70例作为研究组,另选同期行健康体检者70名作为对照组,两组均接受生化检验,对两组生化检验结果进行比较。结果研究组ALT、AST、GGT及ALP指标分别为(27.27±4.28)U/L、(98.48±42.38)U/L、(165.38±34.93)U/L、(182.25±40.79)U/L,均比对照组高,差异有统计学意义(t=17.560、16.649、35.419、19.948,P<0.05);研究组TBIL、TBA、DBIL指标(92.38±24.83)μmol、(68.94±25.66)μmol、(35.24±15.47)μmol均比对照组高,Alb、TP、A/G指标均比对照组低,差异有统计学意义(t=27.123、21.205、16.754、22.066、33.552、15.235,P<0.05)。结论临床对肝硬化疾病进行生化检验检查,其诊断准确率高,能将患者肝细胞合成代谢情况以及肝细胞受损情况反映,可为临床对疾病诊断及治疗提供有效依据。
Objective To analyze the diagnostic value of biochemical test indicators in liver cirrhosis.Methods Selected 70 patients with liver cirrhosis admitted to the hospital from November 2018 to November 2019 as the study group,and selected 70 healthy physical examinations during the same period as the control group.Both groups received biochemical tests,and the biochemical test results of the two groups Compared.Results The indexes of ALT,AST,GGT and ALP in the study group were(27.27±4.28)U/L,(98.48±42.38)U/L,(165.38±34.93)U/L,(182.25±40.79)U/L,respectively,higher than the control group.The difference was statistically significant(t=17.560,16.649,35.419,19.948,P<0.05);the study group TBIL,TBA,DBIL indicators(92.38±24.83)μmol,(68.94±25.66)μmol,(35.24±15.47)μmol,higher than the control group,and the Alb,TP,and A/G indexes were lower than those of the control group.The difference was statistically significant(t=27.123,21.205,16.754,22.066,33.552,15.235,P<0.05).Conclusion Clinical biochemical examinations for liver cirrhosis have a high diagnostic accuracy rate,which can reflect the anabolism of liver cells and liver cell damage in patients,and can provide an effective basis for clinical diagnosis and treatment of the disease.
作者
滕飞
任家琦
TENG Fei;REN Jia-qi(Department of Laboratory Medicine,Liaocheng Fourth People's Hospital,Liaocheng,Shandong Province,252000 China)
出处
《系统医学》
2020年第24期1-3,共3页
Systems Medicine
关键词
生化检验指标
肝硬化
诊断
价值
Biochemical test indicators
Liver cirrhosis
Diagnosis
Value
